GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Quantum Genomics (OTCPK:QNNTF) » Definitions » Research & Development

Quantum Genomics (Quantum Genomics) Research & Development : $7.93 Mil (TTM As of Dec. 2022)


View and export this data going back to 2017. Start your Free Trial

What is Quantum Genomics Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Quantum Genomics's Research & Development for the six months ended in Dec. 2022 was $0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2022 was $7.93 Mil.


Quantum Genomics Research & Development Historical Data

The historical data trend for Quantum Genomics's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Quantum Genomics Research & Development Chart

Quantum Genomics Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Quantum Genomics Semi-Annual Data
Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 6.65 - 7.93 -

Quantum Genomics Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2022 adds up the semi-annually data reported by the company within the most recent 12 months, which was $7.93 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Quantum Genomics  (OTCPK:QNNTF) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Quantum Genomics Research & Development Related Terms

Thank you for viewing the detailed overview of Quantum Genomics's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Quantum Genomics (Quantum Genomics) Business Description

Traded in Other Exchanges
Address
33, Rue Marbeuf, Paris, FRA, 75008
Quantum Genomics is a biopharmaceutical company engaged in developing new products for unmet needs in the field of cardiovascular diseases, high blood pressure, and heart failure. The company products include firibastat, QGC006, QGC011, and others.

Quantum Genomics (Quantum Genomics) Headlines

From GuruFocus

Quantum Genomics Secures �3 Million Non-dilutive Financing

By Marketwired Marketwired 04-28-2021

Quantum Genomics Raises a Gross Amount of Approximately � 15 M

By GuruFocusNews GuruFocusNews 04-26-2022

Quantum Genomics Announces Granting of New Patents Protecting QGC606

By GuruFocusNews GuruFocusNews 03-28-2022